Posted by: Georgia Retina in News, Uncategorized
Drs. Michael S. Jacobson, Scott I. Lampert, and Atul Sharma listed in Atlanta magazine’s July issue, Drs. Jay Stallman and Mark J. Rivellese included in Castle Connolly Top Doctor online listing
June 26, 2014 (Atlanta) — Five doctors from Georgia Retina — one of the largest retina-only medical practices in the southeastern United States — were recently honored as Top Doctors in metro Atlanta.
Drs. Michael S. Jacobson, Scott I. Lampert, and Atul Sharma were named to the 2014 list of Top Doctors in the July issue of Atlanta magazine, and both Drs. Jay Stallman and Mark J. Rivellese were included in the prestigious Top Doctor online listing by Castle Connolly healthcare research company.
The Top Doctors listing is compiled annually by Castle Connolly Medical Ltd. — an established healthcare research company based in New York City. The organization also compiles Atlanta magazine’s list of Top Doctors annually. Doctors are nominated for consideration through both a nationwide survey and a peer nomination process open to licensed doctors in DeKalb, Fulton, Cobb, Clayton, and Gwinnett counties. Castle Connolly’s doctor-led team of researchers then select the Top Doctors through a rigorous screening process that includes an evaluation of educational and professional experience.
Georgia Retina CFO Paul Lucas said the practice is honored to have its doctors recognized as Top Doctors. “We’re incredibly proud that Drs. Jacobson, Lampert, Sharma, Stallman, and Rivellese have been included in these prestigious lists. It’s a wonderful reflection on them and the entire practice for the amazing care they provide to the Atlanta community,” said Lucas.
Dr. Michael S. Jacobson is a board certified ophthalmologist who has been working solely with retinal and vitreous diseases since 1987. Dr. Jacobson graduated from Dartmouth College in Hanover, New Hampshire, and later attended the University of Connecticut School of Medicine in Farmington, Connecticut. He completed his residency at the University of Maryland in Baltimore, Maryland, and a two-year retinal and vitreous fellowship at the University of Illinois Eye and Ear Infirmary in Chicago, Illinois. Dr. Jacobson is a member of the American Medical Association, the Georgia Society of Ophthalmology, the American Society of Retina Specialists, and is a Fellow of the American Academy of Ophthalmology. Dr. Jacobson has been recognized as a Top Doctor for four consecutive years.
Dr. Scott I. Lampert is a board certified ophthalmologist who has practiced in Atlanta, Georgia since 1980, exclusively treating retinal and vitreous diseases. As a graduate of the University of Pennsylvania in Philidelphia, Pennsylvania, Dr. Lampert attended the Thomas Jefferson University School of Medicine also in Philidelphia. He completed his ophthalmology residency at Thomas Jefferson University and Wills Eye Hospital, both in Philadelphia, Pennsylvania. Additionally, he completed a retinal and vitreous fellowship at the University of Pennsylvania. Dr. Lampert is a member of both the Georgia Society of Ophthalmology and the American Society of Retina Specialists, as well as a fellow of the American Academy of Ophthalmology. Dr. Lampert has been recognized as a Top Doctor for four consecutive years.
Dr. Atul Sharma, a board certified ophthalmologist, graduated with honors from the University of California at Berkeley in Berkeley, California before attending Tufts University School of Medicine in Boston, Massachusetts. His ophthalmology residency at the University of Pennsylvania Scheie Eye Institute in Philadelphia, Pennsylvania, was distinguished by his appointment as Chief Resident. Dr. Sharma completed a two-year vitreoretinal fellowship at the Harvard Medical School in Boston, Massachusetts, one of the premier fellowship programs in the nation. He has been an active participant in a number of clinical studies, and his publications have appeared in prominent medical journals. This is Dr. Sharma’s first appearance on the Top Doctors list.
Dr. Jay Stallman is a board certified ophthalmologist and has been in private practice as a vitreo-retinal specialist since 1990. Dr. Stallman graduated with highest honors from the combined six-year program of Boston University School of Medicine in Boston, Massachusetts. After his residency in ophthalmology at the Cleveland Clinic Foundation in Cleveland, Ohio, he completed a two-year fellowship in vitreo-retinal surgery at Tulane Medical Center in New Orleans, Louisiana. Dr. Stallman is a Fellow of the American Academy of Ophthalmology and the American College of Surgeons, and is also a member of the American Society of Retinal Specialists. He has published articles in several professional journals, and regularly serves as an advisor to several journals to select articles submitted for publication. Dr. Stallman has also served as the principal investigator of a number of large multicenter clinical trials conducted at Georgia Retina.
Dr. Mark J. Rivellese is a board certified ophthalmologist. He received his undergraduate and medical education at the State University of New York at Stony Brook in Stony Brook, New York. After completing a general surgery internship and a residency in ophthalmology at Rush Presbyterian — St. Luke’s Medical Center in Chicago, Illinois — he studied medical retina and vitreo-retinal surgery at the New England Eye Center at Tufts University in Boston, Massachusetts. Dr. Rivellese has participated in multiple clinical trials for the investigation of macular degeneration, retinal vascular disease, and retinopathy of prematurity. His particular areas of interest include the medical and surgical treatment of diabetic retinopathy, ocular melanoma, and retinopathy of prematurity.
At Georgia Retina, patients’ vision needs are the top priority. As one of the largest retina-only medical practices in the southeastern United States, Georgia Retina specializes in treating diseases of the retina, macula, and vitreous. Its 11 board certified ophthalmologists have received special Fellowship training in vitreo-retinal diseases and surgery, and are engaged in clinical trials with the goal of advancing research into retinal diseases, their causes, and their cures.
